Head of the radiopharmacy unit at CHUV, I pursue in parallel a PhD program with a research based on the radioimmunotherapy approach for the soft tissue sarcoma diagnosis and treatment in collaboration with Nantes University Hospital (France).
In this project, I study the role of 1C1m-Fc, a new fusion protein antibody radiolabeled with 177Lu on TEM-1 positive tumors.
177Lu-1C1m-Fc dorsal view SPECT/CT fusion maximum intensity projection imaging on mice with TEM-1 positive tumor (SK-N-AS, left flank, red arrow) and TEM-1 negative tumor (HT-1080, right flank, white arrow), (a) at 24 h, (b) at 48 h, (c) at 72 h
